UGT1A1*28 Allele and coronary heart disease: The Rotterdam study

Clinical Chemistry

Volumn 49, Issue 7, 2003, Pages 1180-1181

  Bosma, Piter J ^a   Van Der Meer, Irene M ^b   Bakker, Conny T ^a   Hofman, Albert ^a   Paul Abrahamse, Marianne ^a   Witteman, Jacqueline C ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CHOLESTEROL; DNA; GLUCURONOSYLTRANSFERASE; HIGH DENSITY LIPOPROTEIN; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1;

ADULT; AGE; ALLELE; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; DNA DETERMINATION; ENZYME ACTIVITY; FEMALE; GENDER; GENE INSERTION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEART INFARCTION; HOMOZYGOSITY; HUMAN; HYPOTHESIS; INTERVIEW; ISCHEMIC HEART DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTOLIC BLOOD PRESSURE; AGED; BLOOD; COHORT ANALYSIS; CORONARY ARTERY DISEASE; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

INSERTION SEQUENCES;

AGED; BILIRUBIN; COHORT STUDIES; CORONARY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 0037699938     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/49.7.1180     Document Type: Article

References (14)

1. Epstein FH. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-16.
2. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46:1723-7.
3. Neuzil J, Stocker R. Free and albumin bound bilirubin are efficient co-antioxidants for α-tocopherol, inhibiting plasma and low density lipoprotein peroxidation. J Biol Chem 1994;269:16712-9.
4. Wu TW, Fung KP, Yang CC, Weisel RD. Antioxidation of human low density lipoprotein by unconjugated and conjugated bilirubins. Biochem Pharmacol 1996;51:859-62.
5. Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, et al. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis 2002;160:449-56.
6. Hopkins PH, Wu LL, Hunt SC, James BC, Vincent GM, Williams RR. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol 1995;15:1314-29.
7. Breimer LH, Wannamethee G, Ebrahim S, Sharper AG. Serum bilirubin and risk of ischemic heart disease in middle-aged British men. Clin Chem 1995;41:1504-8.
8. Djousse L, Levy D, Cupples LA, Evans JC, D'Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001;87:1196-200;A4,7.
9. Hunt SC, Kronenberg F, Eckfeldt JH, Hopkins PN, Myers RH, Heiss G. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study. Atherosclerosis 2001;154:747-54.
10. Jansen PL, Bosma PJ, Chowdhury JR. Molecular biology of bilirubin metabolism. Prog Liver Dis 1995;13:125-30.
11. Bosma PJ, Roy Chowdhury J, Bakker C, Gantla S, de Boer A, Oostra B, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyl-transferase 1 in Gilbert's syndrome. N Engl J Med 1995;333:1171-5.
12. Borlak J, Thum T, Landt O, Erb K, Hermann R. Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects. Hepatology 2000;32:792-5.
13. Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA. Determinants of disease and disability in the elderly: the Rotterdam Elderly Study. Eur J Epidemiol 1991;7:403-22.
14. Kelly A, McKenna JP, McLelland A, Percy RA, Spooner RJ. A bichromatic method for total bilirubin with a CentrifiChem 400. Clin Chem 1979;25:1482-4.